Condensed Consolidated Statements Of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended				9 Months Ended
	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
REVENUES:
Net pharmaceutical product sales	$ 652,026		$ 519,843		$ 1,660,878		$ 1,639,890
Devices revenues	109,822		111,244		359,425		359,867
Other revenues	2,090		30,232		56,928		32,204
TOTAL REVENUES	763,938		661,319		2,077,231		2,031,961
COSTS AND EXPENSES:
Cost of revenues	379,199		257,836		976,899		785,630
Selling, general and administrative	205,260		191,362		603,573		662,896
Research and development	30,918		36,687		113,772		108,849
Litigation-related and other contingencies, net	473,338		30,895		1,135,443		159,098
Asset impairment charges	0		807		0		4,756
Acquisition-related and integration items	6,932	[1]	1,493	[1]	71,819	[1]	3,876	[1]
OPERATING (LOSS) INCOME FROM CONTINUING OPERATIONS	(331,709)		142,239		(824,275)		306,856
INTEREST EXPENSE, NET	61,949		43,081		167,528		129,691
LOSS ON EXTINGUISHMENT OF DEBT	2,027		0		31,712		11,312
OTHER INCOME, NET	(4,871)		(14,672)		(17,731)		(49,641)
(LOSS) INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAX	(390,814)		113,830		(1,005,784)		215,494
INCOME TAX	(138,765)		44,655		(338,592)		82,917
(LOSS) INCOME FROM CONTINUING OPERATIONS	(252,049)		69,175		(667,192)		132,577
DISCONTINUED OPERATIONS, NET OF TAX	0		(14,560)		2,251		(3,248)
CONSOLIDATED NET (LOSS) INCOME	(252,049)		54,615		(664,941)		129,329
Less: Net income attributable to noncontrolling interests	35		14,392		2,895		38,758
NET (LOSS) INCOME ATTRIBUTABLE TO ENDO INTERNATIONAL PLC	$ (252,084)		$ 40,223		$ (667,836)		$ 90,571
NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO ENDO INTERNATIONAL PLC ORDINARY SHAREHOLDERS—BASIC:
Continuing operations, basic (usd per share)	$ (1.64)		$ 0.61		$ (4.61)		$ 1.18
Discontinued operations, basic (usd per share)	$ 0.00		$ (0.26)		$ (0.01)		$ (0.38)
Basic (usd per share)	$ (1.64)		$ 0.35		$ (4.62)		$ 0.80
Continuing operations, diluted (usd per share)	$ (1.64)		$ 0.58		$ (4.61)		$ 1.13
Discontinued operations, diluted (usd per share)	$ 0.00		$ (0.25)		$ (0.01)		$ (0.36)
Diluted (usd per share)	$ (1.64)		$ 0.33		$ (4.62)		$ 0.77
WEIGHTED AVERAGE SHARES:
Basic (shares)	153,309		114,327		144,604		112,691
Diluted (shares)	153,309		120,261		144,604		116,890

[1] Acquisition-related and integration-items include costs directly associated with the closing of certain acquisitions, changes in the fair value of contingent consideration and the costs of integration activities related to both current and prior period acquisitions.